Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medtide, Inc. Class H ( (HK:3880) ) has provided an announcement.
Medtide Inc. has completed the conversion of 68,201,112 unlisted shares into H shares, with trading of these converted H shares on the Hong Kong Stock Exchange set to begin on March 10, 2026. Following this full circulation move, all 141,800,000 issued shares of the company are now H shares, simplifying the shareholding structure and potentially enhancing liquidity for investors, though shareholders are cautioned to exercise care when trading the stock.
The most recent analyst rating on (HK:3880) stock is a Hold with a HK$38.00 price target. To see the full list of analyst forecasts on Medtide, Inc. Class H stock, see the HK:3880 Stock Forecast page.
More about Medtide, Inc. Class H
Medtide Inc. is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong as an H-share issuer. The company operates in the medical sector, and its H shares trade on the Main Board of The Stock Exchange of Hong Kong, giving it access to international capital and a broader investor base.
Average Trading Volume: 130,955
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$3.2B
See more data about 3880 stock on TipRanks’ Stock Analysis page.